{"title": "Novartis Archives", "author": null, "url": "https://www.europeanpharmaceuticalreview.com/organisations/novartis/", "hostname": "europeanpharmaceuticalreview.com", "description": "News stories and articles referencing Novartis on European Pharmaceutical Review", "sitename": "European Pharmaceutical Review", "date": "2022-10-17", "cleaned_text": "cancer](https://www.europeanpharmaceuticalreview.com/news/175271/chmp-recommends-pluvicto-for-treating-advanced-prostate-cancer/) CHMP issues positive opinion on Pluvicto\u00ae, paving the way for it to become the first European-approved radioligand therapy for metastatic prostate cancer patients. "}